FDA Approves Ipilimumab, An Immunotherapy, To Treat Metastatic Melanoma
Friday, March 25, 2011 - 14:00
in Health & Medicine
Ipilimumab, a monoclonal antibody, received FDA approval today to treat advanced melanoma. This first-in-class antibody drug may also significantly improve standard cancer treatments.